Johnson & Johnson (JNJ) has shined in the healthcare space, rallying 5% this week and 30% in 2025. An upgrade from Wells Fargo added momentum to the stock rally on Friday. Rick Ducat dives into the price action behind Johnson & Johnson by comparing the stock to peers in pharmaceuticals and the general health care sector. He analyzes the options front gauge and expected volatility on both sides of the trade.
Market On Close
04 Oct 2025
SHARE